259 related articles for article (PubMed ID: 8413267)
21. Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1.
Fixman ED; Holgado-Madruga M; Nguyen L; Kamikura DM; Fournier TM; Wong AJ; Park M
J Biol Chem; 1997 Aug; 272(32):20167-72. PubMed ID: 9242692
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2.
Kortenjann M; Thomae O; Shaw PE
Mol Cell Biol; 1994 Jul; 14(7):4815-24. PubMed ID: 8007980
[TBL] [Abstract][Full Text] [Related]
23. Two mutations affecting conserved residues in the Met receptor operate via different mechanisms.
Maritano D; Accornero P; Bonifaci N; Ponzetto C
Oncogene; 2000 Mar; 19(10):1354-61. PubMed ID: 10713677
[TBL] [Abstract][Full Text] [Related]
24. An 11-amino acid sequence from c-met initiates epithelial chemotaxis via phosphatidylinositol 3-kinase and phospholipase C.
Derman MP; Chen JY; Spokes KC; Songyang Z; Cantley LG
J Biol Chem; 1996 Feb; 271(8):4251-5. PubMed ID: 8626770
[TBL] [Abstract][Full Text] [Related]
25. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
[TBL] [Abstract][Full Text] [Related]
26. A protein tyrosine phosphatase activity associated with the hepatocyte growth factor/scatter factor receptor.
Villa-Moruzzi E; Lapi S; Prat M; Gaudino G; Comoglio PM
J Biol Chem; 1993 Aug; 268(24):18176-80. PubMed ID: 7688741
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase.
Gandino L; Longati P; Medico E; Prat M; Comoglio PM
J Biol Chem; 1994 Jan; 269(3):1815-20. PubMed ID: 8294430
[TBL] [Abstract][Full Text] [Related]
28. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.
Kitayama H; Kanakura Y; Furitsu T; Tsujimura T; Oritani K; Ikeda H; Sugahara H; Mitsui H; Kanayama Y; Kitamura Y
Blood; 1995 Feb; 85(3):790-8. PubMed ID: 7530509
[TBL] [Abstract][Full Text] [Related]
29. The Met proto-oncogene mesenchymal to epithelial cell conversion.
Tsarfaty I; Rong S; Resau JH; Rulong S; da Silva PP; Vande Woude GF
Science; 1994 Jan; 263(5143):98-101. PubMed ID: 7505952
[TBL] [Abstract][Full Text] [Related]
30. Expression and characterization of hepatocyte growth factor receptor-IgG fusion proteins. Effects of mutations in the potential proteolytic cleavage site on processing and ligand binding.
Mark MR; Lokker NA; Zioncheck TF; Luis EA; Godowski PJ
J Biol Chem; 1992 Dec; 267(36):26166-71. PubMed ID: 1334493
[TBL] [Abstract][Full Text] [Related]
31. Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization.
Dang CV; Barrett J; Villa-Garcia M; Resar LM; Kato GJ; Fearon ER
Mol Cell Biol; 1991 Feb; 11(2):954-62. PubMed ID: 1990293
[TBL] [Abstract][Full Text] [Related]
32. Transformation and transactivation suppressor activity of the c-Jun leucine zipper fused to a bacterial repressor.
Granger-Schnarr M; Benusiglio E; Schnarr M; Sassone-Corsi P
Proc Natl Acad Sci U S A; 1992 May; 89(10):4236-9. PubMed ID: 1584758
[TBL] [Abstract][Full Text] [Related]
33. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
Iwama A; Yamaguchi N; Suda T
EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
[TBL] [Abstract][Full Text] [Related]
34. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation.
Anastasi S; Giordano S; Sthandier O; Gambarotta G; Maione R; Comoglio P; Amati P
J Cell Biol; 1997 Jun; 137(5):1057-68. PubMed ID: 9166406
[TBL] [Abstract][Full Text] [Related]
35. Cross-talk between the proto-oncogenes Met and Ron.
Follenzi A; Bakovic S; Gual P; Stella MC; Longati P; Comoglio PM
Oncogene; 2000 Jun; 19(27):3041-9. PubMed ID: 10871856
[TBL] [Abstract][Full Text] [Related]
36. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
37. Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.
Mercalli E; Ghizzoni S; Arighi E; Alberti L; Sangregorio R; Radice MT; Gishizky ML; Pierotti MA; Borrello MG
Oncogene; 2001 Jun; 20(27):3475-85. PubMed ID: 11429694
[TBL] [Abstract][Full Text] [Related]
38. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
Michieli P; Basilico C; Pennacchietti S; Maffè A; Tamagnone L; Giordano S; Bardelli A; Comoglio PM
Oncogene; 1999 Sep; 18(37):5221-31. PubMed ID: 10498872
[TBL] [Abstract][Full Text] [Related]
39. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.
Weidner KM; Sachs M; Birchmeier W
J Cell Biol; 1993 Apr; 121(1):145-54. PubMed ID: 8384622
[TBL] [Abstract][Full Text] [Related]
40. MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential.
Williams TA; Longati P; Pugliese L; Gual P; Bardelli A; Michieli P
J Cell Physiol; 1999 Dec; 181(3):507-14. PubMed ID: 10528237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
